Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | CEP170 |
| Upstream (Parents) |
|---|
| (<<) BCL3 → CEP170 |
| (<<) CCDC108 → CEP170 |
| (<<) CYP1A2 → CEP170 |
| (<<) DRD4 → CEP170 |
| (<<) E2F3 → CEP170 |
| (<<) FGFBP1 → CEP170 |
| (<<) GLS → CEP170 |
| (<<) GOT1 → CEP170 |
| (<<) GRB10 → CEP170 |
| (<<) IL23A → CEP170 |
| (<<) LOC100131581 → CEP170 |
| (<<) MYL7 → CEP170 |
| (<<) PHLDA1 → CEP170 |
| (<<) PLA2R1 → CEP170 |
| (<<) PRKCH → CEP170 |
| (<<) PTK7 → CEP170 |
| (<<) THBS1 → CEP170 |
| (<<) TMEM158 → CEP170 |
| Downstream (Children) |
|---|
| CEP170 → AIFM1 (>>) |
| CEP170 → ATP2B4 (>>) |
| CEP170 → CALM3 (>>) |
| CEP170 → CASP9 (>>) |
| CEP170 → CDC42EP2 (>>) |
| CEP170 → CHSY1 (>>) |
| CEP170 → CLK3 (>>) |
| CEP170 → CREBBP (>>) |
| CEP170 → CSGALNACT2 (>>) |
| CEP170 → FAM46B (>>) |
| CEP170 → GOT2 (>>) |
| CEP170 → GRPEL1 (>>) |
| CEP170 → HDAC3 (>>) |
| CEP170 → HMGA2 (>>) |
| CEP170 → ILKAP (>>) |
| CEP170 → LOC92249 (>>) |
| CEP170 → LRRC8C (>>) |
| CEP170 → MREG (>>) |
| CEP170 → PCK2 (>>) |
| CEP170 → PKIB (>>) |
| CEP170 → POU3F3 (>>) |
| CEP170 → RASSF1 (>>) |
| CEP170 → RNASE7 (>>) |
| CEP170 → SGMS2 (>>) |
| CEP170 → SOX8 (>>) |
| CEP170 → STK40 (>>) |
| CEP170 → THRA (>>) |
| CEP170 → UAP1 (>>) |
